Skip to search formSkip to main contentSkip to account menu

KW 2307

Known as: KW-2307 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Phase I study on a new vinca alkaloid derivative, KW-2307(vinorelbine), was conducted by multiple institutions in 40 patients… 
1994
1994
The In vitro antitumor activity of navelbine (NVB, KW- 2307), a newly synthesized vlnca alkaloid, was compared with that of… 
1994
1994
A multi-institutional early phase II study of KW-2307 (vinorelbine), a new vinca alkaloid derivative, in advanced or recurrent… 
1994
1994
A phase-I clinical study with coadministration of a new vinca alkaloid derivative KW-2307 with cisplatin (CDDP) at 80 mg/m2 to… 
1994
1994
A multi-institutional late phase II study of KW-2307 (vinorelbine), a new vinca alkaloid derivative, in advanced or recurrent… 
1993
1993
The in vivo combination effect of navelbine (NVB, KW-2307) plus cisplatin was compared with that of vindesine (VDS) plus… 
1992
1992
The combination effect of navelbine (NVB, KW‐2307), a newly synthesized vinca alkaloid, and cisplatin (CDDP) was compared with…